BTI
NEO icon

Blue Trust Inc’s NeoGenomics NEO Stock Holding History

Blue Trust Inc’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,125
Closed -$18.5K – 2532
2024
Q4 		$18.5K Sell
1,125
-2,193
-66% -$34.1K ﹤0.01% 1619
2024
Q3 		$46K Buy
3,318
+987
+42% +$15.4K ﹤0.01% 1604
2024
Q2 		$36.6K Buy
2,331
+1,206
+107% +$17.1K ﹤0.01% 1393
2024
Q1 		$17.7K Sell
1,125
-519
-32% -$8.01K ﹤0.01% 1273
2023
Q4 		$21K Sell
1,644
-606
-27% -$9.92K ﹤0.01% 1266
2023
Q3 		$36K Hold
2,250
– – ﹤0.01% 968
2023
Q2 		$39K Sell
2,250
-70
-3% -$1.15K ﹤0.01% 786
2023
Q1 		$21K Buy
2,320
+17
+0.7% +$242 ﹤0.01% 1346
2022
Q4 		$20K Hold
2,303
– – ﹤0.01% 1300
2022
Q3 		$19K Sell
2,303
-3
-0.1% -$30 ﹤0.01% 1117
2022
Q2 		$28K Buy
+2,306
New +$22K ﹤0.01% 853

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Blue Trust Inc's NEO Position: Q1 2025 in Review

Blue Trust Inc sold out of NeoGenomics (NEO) in Q1 2025, closing a stake of 1,125 shares — an estimated $18.5K sold.

Blue Trust Inc first reported a position in NEO in Q2 2022 and held it in 11 quarters. The position peaked at $46K in Q3 2024. 256 funds tracked by Wall St. Rank hold NEO as of Q1 2025.

  • Blue Trust Inc reported no remaining NeoGenomics position as of Q1 2025 after selling out during the quarter.
  • Blue Trust Inc sold 1,125 NeoGenomics shares in Q1 2025, an estimated $18.5K.
  • Blue Trust Inc first reported a position in NeoGenomics in Q2 2022 and held it in 11 quarters.
  • Blue Trust Inc's NeoGenomics position peaked at $46K in Q3 2024.
  • 256 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2025.

Based on Blue Trust Inc's 13F filing for Q1 2025, filed 21 Apr 2025.